SB
Therapeutic Areas
Opna Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Zavabresib (OPN-2853) | Myelofibrosis | Phase 1 |
| OPN-6602 | Multiple Myeloma | Phase 1 |
| Multi-functional Degraders | Myeloma and Lymphoma | Preclinical |
| OPN-FMRP | Solid Tumors | Research |
| Drug | Indication | Phase |
|---|---|---|
| Zavabresib (OPN-2853) | Myelofibrosis | Phase 1 |
| OPN-6602 | Multiple Myeloma | Phase 1 |
| Multi-functional Degraders | Myeloma and Lymphoma | Preclinical |
| OPN-FMRP | Solid Tumors | Research |